Marsh & McLennan Companies (MRSH) Earnings Analysis
Marsh & McLennan Companies (MRSH) next reports earnings on 2026-10-15, consensus EPS 1.98 USD. Last quarter (2026-07-21) it beat with EPS 2.96 USD vs 2.88 USD est (+2.8%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 21.44.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MRSH next report earnings?
| Next earnings date | 2026-10-15 |
|---|---|
| Consensus EPS estimate | 1.98 USD |
| Revenue estimate | 6.65B |
MRSH earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-21 | 2.96 USD | 2.88 USD | +2.8% | Beat |
| 2026-04-16 | 3.29 USD | 3.22 USD | +2.2% | Beat |
| 2026-01-29 | 2.12 USD | 1.97 USD | +7.6% | Beat |
| 2025-10-16 | 1.85 USD | 1.78 USD | +3.9% | Beat |
| 2025-07-17 | 2.72 USD | 2.67 USD | +1.9% | Beat |
| 2025-04-17 | 3.06 USD | 3.02 USD | +1.3% | Beat |
| 2025-01-30 | 1.87 USD | 1.76 USD | +6.3% | Beat |
| 2024-10-17 | 1.63 USD | 1.61 USD | +1.2% | Beat |
Beat rate: 8/8 (100%) over reported quarters with consensus data.
MRSH valuation and analyst view
| Trailing P/E | 21.44 |
|---|---|
| Trailing EPS | 8.257 USD |
| Price / book | 5.50 |
| Dividend yield | 2.10% |
| Market cap | 85.36B |
| Analyst consensus | Hold (11 buy / 22 hold / 1 sell) |
| Avg price target | 195.2 USD |
Related research pages
Frequently asked questions
When is Marsh & McLennan Companies (MRSH)'s next earnings date?
Marsh & McLennan Companies is next scheduled to report on 2026-10-15, with a consensus EPS estimate of 1.98 USD and revenue estimate of 6.65B.
Did MRSH beat earnings last quarter?
In its 2026-07-21 report, MRSH posted EPS of 2.96 USD versus a 2.88 USD estimate — a beat of 2.8%.
What is MRSH's earnings track record?
Over the last 8 reported quarters with consensus data, MRSH beat estimates 8 times (100%).
What is MRSH's current P/E ratio and EPS?
MRSH trades at a trailing P/E of 21.44 on trailing EPS of 8.257261410788383 USD.
What do analysts rate MRSH?
Analyst consensus is "Hold" across 34 ratings (1 strong buy, 10 buy, 22 hold, 1 sell, 0 strong sell). Average 12-month price target: 195.2 USD.